Peer-reviewed journals

1. Arnold C, Feldner A, Zappe M,  Komljenovic D, De La Torre C, Ruzicka P, Hecker M, Neuhofer W, Korff T. Genetic ablation of NFAT5/TonEBP in smooth muscle cells impairs flow- and pressure-induced arterial remodeling in mice. FASEB J, 2018, doi: 10.1096/fj.201801594R.

2. Niland S, Komljenovic D, Macas J, Bracht T, BäuerleT, Liebner S, Eble JA. Rhodocetin-alpha/beta selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models. Oncotarget, 2018, 9(32):22406-22422

3. Feldner A, Adam G, Tetzlaff F, Moll I, Komljenovic D, Sahm F, Bäuerle T, Ishikawa H, Schroten H, Korff T, Hofmann I, Wolburg H, von Deimling A, Fischer A. Loss of Mpdz impairs ependymal cell integrity leading to perinatal-onset hydrocephalus in mice. EMBO Molecular Medicine, 2017, 9(7):890-905

4. Mogler C, König C, Wieland M, Runge A, Besemfelder E, Komljenovic D, Longerich T, Schirmacher P, Augustin H. Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin. EMBO Molecular Medicine, 2017, 9(6):741-749

5. Komljenovic D, Wiessler M, Waldeck W, Ehemann V, Pipkorn R, Schrenk HH, Debus J, Braun K. NIR-cyanine dye linker: a promising candidate for isochronic fluorescence imaging in molecular cancer diagnostics and therapy monitoring. Theranostics, 2016, 6(1):131-41

6. Schröder H, Komljenovic D, Hecker M, Korff T. Elevated tumor perfusion stimulates peripheral blood vessel growth. FASEB Journal, 2016, 30(2):923-32 

7. Mogler C, Wieland M, Hu Y, Runge A, Korn C, Besemfelder E, Breitkopf K, Komljenovic D, Dooley S, Schirmacher P, Longerich T, Augustin H. Hepatic stellate cell expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. EMBO Molecular Medicine, 2015, 13;7(3):332-8

8. Yang Y, Gorzelanny C, Bauer AT, Halter N, Komljenovic D, Bäuerle T, Borsig L, Roblek M, Schneider S. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity. Oncogene, 2015, 34(47):5832-42 

9. Pipkorn R, Braun K, Wießler M, Waldeck W, Schrenk HH, Koch M, Semmler W, Komljenovic D. A peptide and peptide nucleic acid synthesis technology for transporter molecules and theranostics - the SPPS. International Journal of Medical Sciences, 2014, 11(7): 697-706

10. Runge A, Hu J, Wieland M, Bergeest JP, Mogler C, Neumann A, Géraud C, Arnold B, Rohr K, Komljenovic D, Schirmacher P, Goerdt S, Augustin H. An inducible hepatocellular carcinoma model for preclinical evaluation of anti-angiogenic therapy in adult mice. Cancer Research, 2014, 74(15):4157-69

11. Braun J, Strittmatter K, Nübel T, Komljenovic D, Sator-Schmitt M, BäuerleT, Angel P, Schorpp-Kistner M. Loss of stromal Junb does not affect tumor growth and angiogenesis. International Journal of Cancer, 2014, 134(6):1511-6 

12. Bäuerle T, Komljenovic D, Berger M, Semmler W. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastases using magnetic resonance imaging, volumetric computed tomography and ultrasound. The Journal of Visual Experiments, 2012, 14(66);4178 

13. Merz M, Komljenovic D, Semmler W, Bäuerle T. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases. Investigative Radiology, 2012, 47(7):422-9

14. Bäuerle T, Komljenovic D, Semmler W. Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging. Current Pharmaceutical Biotechnology, 2012, 13(4):584-84

15. Mühlhausen U, Komljenovic D, Bretschi M, Leotta K, Eisenhut M, Semmler W, Bäuerle T. A novel PET tracer for the imaging of alphav/beta3 and alphav/beta5 integrins in experimental breast cancer bone metastases. Contrast Media & Molecular Imaging, 2011, 6(6):413-20 

16. Bretschi M, Merz M, Komljenovic D, Berger M, Semmler W, Bäuerle T. Cilengitide inhibits metastatic bone colonization in a nude rat model. Oncology Reports, 2011, 26(4):843-51 

17. Cheng C, Komljenovic D, Pan L, Dimitrakopoulou-Strauss A, Strauss L, Bäuerle T. Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG. Hellenic Journal of Nuclear Medicine, 2011, 14(1):15-20 

18. Merz M, Komljenovic D, Zwick S, Semmler W, Bäuerle T. Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases. European Journal of Cancer, 2011, 47(2):277-86 

19. Bäuerle T/Komljenovic D (contributed equally), Merz M, Berger M, Goodman SL, Semmler W. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged non-invasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. International Journal of Cancer, 2011, 128(10):2453-62 

20. Bäuerle T, Merz M, Komljenovic D, Zwick S, Semmler W. Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo Study. Clinical Cancer Research, 2010, 16(12):3215–25 

Book chapters

1. Komljenovic D. MRT-Kontrastmittel (Chapter 9.6). In: Medizinische Physik (Editors W. Schlegel, C. Karger and O. Jäkel), Springer, 2018, ISBN 978-3-662-54800-4.

2. Komljenovic D, Bäuerle T. Ultrasound Imaging of Cancer Therapy (Chapter 8). In: Cancer Theranostics (Editors X. Chen and S. Wong), Elsevier, 2014, ISBN 978-0-12-407722-5.

Conference proceedings

to top
powered by webEdition CMS